Teva Pharmaceutical Industries Ltd at Bank of America Global Healthcare Conference Transcript
I think we're rolling, judging by the clock here. So thank you, Richard, for joining us here at the BofA Global Healthcare Conference in London. My name is Jason Gerberry. I'm one of the SMID cap biotech and specialty pharma analysts. And so pleased to be introducing our next company presenter, Teva Pharmaceuticals and Richard Francis, CEO.
Richard, it's been, what, about 18 months on the job. And a lot has changed, I think, for the better. I think your predecessor was focused on dealing with some legacy issues with the company in terms of leverage and some litigation matters. And then you've been able to come in and now start to orient the company towards more of a growth-driven strategy.
Questions & Answers
So I don't know if you want to maybe just level set for the group here, just kind of what you've observed at Teva, some of the good, the bad and kind of where you see the company going.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
